Insights

Global Market Reach CSL operates in over 100 countries, providing a vast potential customer base for healthcare providers, distributors, and biotechnology partners seeking lifesaving medicines and vaccines.

Innovative Portfolio With a focus on breakthrough therapies for hemophilia, immune deficiencies, and infectious diseases, CSL offers unique opportunities to collaborate on cutting-edge biopharmaceutical solutions tailored to market needs.

Financial Strength Generating over 10 billion dollars in revenue and maintaining strategic investments, CSL is positioned as a financially stable partner for long-term collaborations and joint ventures in biotech and healthcare sectors.

R&D Leadership CSL’s emphasis on research and development combined with advanced technologies presents opportunities for technology providers and research collaborations to enhance product innovation and manufacturing efficiency.

Expanding Business Units With diversified subsidiaries like CSL Behring and CSL Seqirus, there are opportunities to develop targeted sales strategies addressing specific segments such as immunology, infectious diseases, and specialty medicines.

CSL Tech Stack

CSL uses 8 technology products and services including SAS/GRAPH, Open Graph, Sage X3, and more. Explore CSL's tech stack below.

  • SAS/GRAPH
    Business Intelligence
  • Open Graph
    Content Management System
  • Sage X3
    Enterprise Resource Planning
  • Dynatrace
    System Analytics & Monitoring
  • ComOps
    Time Tracking
  • Timesheets
    Time Tracking
  • Skype for Business
    Unified Communications
  • VMWare NSX
    Virtualisation Software

Media & News

CSL's Email Address Formats

CSL uses at least 2 format(s):
CSL Email FormatsExamplePercentage
First.Last@csl.com.auJohn.Doe@csl.com.au
93%
FLast@csl.com.auJDoe@csl.com.au
4%
First_Last@csl.com.auJohn_Doe@csl.com.au
1%
FirstMiddle.Last@csl.com.auJohnMichael.Doe@csl.com.au
1%
First.L@csl.com.auJohn.D@csl.com.au
1%
First.Last@csl.comJohn.Doe@csl.com
92%
FirstLast@csl.comJohnDoe@csl.com
6%
FirstL@csl.comJohnD@csl.com
2%

Frequently Asked Questions

Where is CSL's headquarters located?

Minus sign iconPlus sign icon
CSL's main headquarters is located at 655 Elizabeth Street Melbourne, Victoria 3000 Australia. The company has employees across 6 continents, including North AmericaOceaniaEurope.

What is CSL's phone number?

Minus sign iconPlus sign icon
You can contact CSL's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CSL's stock symbol?

Minus sign iconPlus sign icon
CSL is a publicly traded company; the company's stock symbol is CSL.

What is CSL's official website and social media links?

Minus sign iconPlus sign icon
CSL's official website is csl.com and has social profiles on LinkedInCrunchbase.

What is CSL's SIC code NAICS code?

Minus sign iconPlus sign icon
CSL's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CSL have currently?

Minus sign iconPlus sign icon
As of February 2026, CSL has approximately 23K employees across 6 continents, including North AmericaOceaniaEurope. Key team members include Ceo & Managing Director: P. M.Cfo Brazil: M. D. N. G.Cmo Campaign Manager, Americas: A. D. T.. Explore CSL's employee directory with LeadIQ.

What industry does CSL belong to?

Minus sign iconPlus sign icon
CSL operates in the Biotechnology Research industry.

What technology does CSL use?

Minus sign iconPlus sign icon
CSL's tech stack includes SAS/GRAPHOpen GraphSage X3DynatraceComOpsTimesheetsSkype for BusinessVMWare NSX.

What is CSL's email format?

Minus sign iconPlus sign icon
CSL's email format typically follows the pattern of First.Last@csl.com.au. Find more CSL email formats with LeadIQ.

How much funding has CSL raised to date?

Minus sign iconPlus sign icon
As of February 2026, CSL has raised $111M in funding. The last funding round occurred on Feb 06, 2004 for $111M.

CSL

Biotechnology ResearchVictoria, Australia10001+ Employees

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.

Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.

See our community guidelines: https://bit.ly/3Bs17Ra

Section iconCompany Overview

Headquarters
655 Elizabeth Street Melbourne, Victoria 3000 Australia
Phone number
Website
csl.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CSL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
10001+

Section iconFunding & Financials

  • $111M

    CSL has raised a total of $111M of funding over 1 rounds. Their latest funding round was raised on Feb 06, 2004 in the amount of $111M.

  • $10B

    CSL's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $111M

    CSL has raised a total of $111M of funding over 1 rounds. Their latest funding round was raised on Feb 06, 2004 in the amount of $111M.

  • $10B

    CSL's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.